Trademark: 88223034
Status Date
Monday, June 13, 2022
Filing Date
Monday, December 10, 2018
Published for Opposition
Tuesday, March 12, 2019
Abandoned Date
Monday, June 13, 2022
5 Pharmaceutical preparations for the prevention and treatment of Alzheimer's disease; Pharmaceutical preparations for the prevention and treatment of depression; Pharmaceutical preparations for the prevention and treatment of psychological disorders; Pharmaceutical preparations for the prevention and treatment of diabetes and diabetic neuropathy; Pharmaceutical preparations for the prevention and treatment of cardiovascular and blood pressure disorders; Pharmaceutical preparations for the prevention and treatment of irritable bowel syndrome; Pharmaceutical preparations for the prevention and treatment of neurodegenerative diseases and disorders; Pharmaceutical preparations for the prevention and treatment of osteoporosis; Pharmaceutical preparations for the prevention and treatment of pain and neuropathic pain; Pharmaceutical preparations for the prevention and treatment of peripheral nervous system diseases and disorders; Pharmaceutical preparations for the prevention and treatment of digestive tract, gastrointestinal and dermatological diseases and disorders; Pharmaceutical preparations for the prevention and treatment of respiratory system diseases and disorders; Pharmaceutical preparations for the prevention and treatment of sexual dysfunction; Pharmaceutical preparations for the prevention and treatment of symptoms associated with uterine fibroids; Pharmaceutical preparations for the prevention and treatment of urinary incontinence and overactive bladder; Pharmaceutical preparations for the prevention and treatment of AIDS-related disorders; Pharmaceutical preparations that support, encourage and promote bone strength; Pharmaceutical preparations that support, encourage and promote bone health; Pharmaceutical preparations used in the treatment of bone disorders and bone diseases; Pharmaceutical preparations, namely, injectable contraceptives; Pharmaceutical preparations, namely, contraceptive preparations; Pharmaceutical preparations, namely, fertility enhancement preparations; Pharmaceutical preparations, namely, hormone replacement therapy preparations; Pharmaceutical preparations for the treatment of cancer; Pharmaceutical agents affecting the central nervous system; Pharmaceutical agents affecting circulatory systems; Pharmaceutical agents affecting sensory organs; Pharmaceutical agents affecting urogenital organs; Pharmaceutical agents affecting peripheral nervous system; Pharmaceutical preparations, namely, oral and injectable contraceptives, women's hormone replacement medications
Jun 13, 2022
Abandonment Notice E-Mailed - No Use Statement Filed
Jun 13, 2022
Abandonment - No Use Statement Filed
Nov 11, 2021
Notice Of Approval Of Extension Request E-Mailed
Nov 10, 2021
Sou Extension 5 Granted
Nov 2, 2021
Sou Extension 5 Filed
Nov 10, 2021
Case Assigned To Intent To Use Paralegal
Nov 4, 2021
Teas Extension Received
Nov 2, 2021
Teas Extension Received
May 11, 2021
Notice Of Approval Of Extension Request E-Mailed
May 7, 2021
Sou Extension 4 Granted
May 7, 2021
Sou Extension 4 Filed
May 7, 2021
Teas Extension Received
Nov 4, 2020
Notice Of Approval Of Extension Request E-Mailed
Nov 2, 2020
Sou Extension 3 Granted
Nov 2, 2020
Sou Extension 3 Filed
Nov 2, 2020
Teas Extension Received
May 6, 2020
Notice Of Approval Of Extension Request E-Mailed
May 4, 2020
Sou Extension 2 Granted
May 4, 2020
Sou Extension 2 Filed
May 4, 2020
Teas Extension Received
Nov 5, 2019
Teas Change Of Correspondence Received
Nov 7, 2019
Notice Of Approval Of Extension Request E-Mailed
Nov 5, 2019
Sou Extension 1 Granted
Nov 5, 2019
Sou Extension 1 Filed
Nov 5, 2019
Teas Extension Received
May 7, 2019
Noa E-Mailed - Sou Required From Applicant
Mar 12, 2019
Official Gazette Publication Confirmation E-Mailed
Mar 12, 2019
Published For Opposition
Feb 20, 2019
Notification Of Notice Of Publication E-Mailed
Jan 29, 2019
Approved For Pub - Principal Register
Jan 29, 2019
Assigned To Examiner
Jan 2, 2019
New Application Office Supplied Data Entered In Tram
Dec 13, 2018
New Application Entered In Tram
Trademark Alertz updated from USPTO on 2030-01-24
